Aishwarya Lifesciences retains India Juris

01 May 2014

Aishwarya Lifesciences is among TOP-5 companies in India, producing sterile solutions using FFS technology. It is an associate company of Alkem Laboratories, one of the leaders in Indian Pharmaceutical industry.

Aishwarya Lifesciences has retained India Juris in a dispute resolution matter against a large corporation.

News & Deals

IJ acted as legal counsel to the investor on its Pre-Series A investment in Rotoris

In INR 32.5 Cr funding round of 1BUY.AI, IJ represents lead investor

Scrap Uncle Pre Series A Round – IJ represents one of the participating investors

Obtaining a Payment Services Provider (PSP) Licence in GIFT IFSC: Regulatory Framework under IFSCA

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Reframing Liquidation Under IBC: Transitioning From Sale as a Going Concern to Asset-Based Realisation

IFSCA Introduces Regulatory Amendments and Revised Fee Framework to Strengthen the GIFT-IFSC Ecosystem

Regulatory Update – SEBI Circulars (March 2026)

India Expands Crypto-Asset Reporting Under the Income-tax Framework

Aishwarya Lifesciences retains India Juris

Aishwarya Lifesciences retains India Juris

News & Deals

IJ acted as legal counsel to the investor on its Pre-Series A investment in Rotoris

In INR 32.5 Cr funding round of 1BUY.AI, IJ represents lead investor

Scrap Uncle Pre Series A Round – IJ represents one of the participating investors

Publications

Obtaining a Payment Services Provider (PSP) Licence in GIFT IFSC: Regulatory Framework under IFSCA

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Reframing Liquidation Under IBC: Transitioning From Sale as a Going Concern to Asset-Based Realisation

Newsletters

IFSCA Introduces Regulatory Amendments and Revised Fee Framework to Strengthen the GIFT-IFSC Ecosystem

Regulatory Update – SEBI Circulars (March 2026)

India Expands Crypto-Asset Reporting Under the Income-tax Framework